Role of HMGB1 in Cutaneous Melanoma: State of the Art

Abstract

High-mobility Group Box 1 (HMGB1) is a nuclear protein that plays a key role in acute and chronic inflammation. It has already been studied in several diseases, among them melanoma. Indeed, HMGB1 is closely associated with cell survival and proliferation and may be directly involved in tumor cell metastasis development thanks to its ability to promote cell migration. This research aims to assess the role of this molecule in the pathogenesis of human melanoma and its potential therapeutic role. The research has been conducted on the PubMed database, and the resulting articles are sorted by year of publication, showing an increasing interest in the last five years. The results showed that HMGB1 plays a crucial role in the pathogenesis of skin cancer, prognosis, and therapeutical response to therapy. Traditional therapies target this molecule indirectly, but future perspectives could include the development of new target therapy against HMGB1, thus adding a new approach to the therapy, which has often shown primary and secondary resistance. This could add a new therapy arm which has to be prolonged and specific for each patient.

Rosmarinus officinalis and Skin: Antioxidant Activity and Possible Therapeutical Role in Cutaneous Diseases

“…Thus, in vitro and in vivo data also indicated that crude extracts or purified components of rosemary exerted chemoprotective effects, inhibiting the early stages of tumor development [ 112 , 113 ], probably through the inhibition of enzymes of stage I carcinogenesis. Among the tumors with a rapidly increasing incidence rate, melanoma is a malignant tumor induced by the transformation of melanocytes [ 114 ]. When metastatic, the prognosis of melanoma becomes very bad, especially due to the poor response to the currently approved therapies.…”

NETosis as an oncologic therapeutic target: a mini review

“…In non-alcoholic steatohepatitis, NETosis has been linked to hepatocellular cancer development and metastasis ( 25 , 26 ). Neutrophil activation by high mobility group box 1 protein (HMGB1) is implicated in melanoma metastasis ( 27 , 28 ).…”

Oxidative Stress and Phototherapy in Atopic Dermatitis: Mechanisms, Role, and Future Perspectives

“…In addition to AD, OS role has been demonstrated in several chronic cutaneous diseases, including psoriasis, vitiligo, alopecia areata (AA), lichen planus, pemphigus vulgaris, and skin cancers [ 68 , 69 , 70 , 71 , 72 ]. On this topic, psoriasis is a chronic, immune-mediated inflammatory cutaneous disease, mainly characterized by the presence of erythematous plaques, covered by white scales, especially localized over the extensor zones [ 73 ].…”